Content by Institute of Cancer Research
|4 min read
Major Trial Uses Blood Test to Match Women with Breast Cancer to Precision Treatments
Trial provides the strongest evidence yet that simple blood tests known as liquid biopsies can benefit women with breast cancer by tracking their disease as it evolves
|3 min read
Olaparib Becomes First Gene-Targeted Medicine to Show Benefits in Prostate Cancer
The phase II trial found that over 80 percent of men with prostate cancer whose tumors had mutations in the BRCA genes responded well to treatment with the targeted drug olaparib
|3 min read
Prostate Cancer 'Super Responders' Live for 2 Years on Immunotherapy
Recent study finds that one in 20 men with end-stage prostate cancer responded to the immunotherapy pembrolizumabPage 1 of 1
